BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8382039)

  • 1. Differential serologic responses to reassortant bluetongue viruses recovered from a bull.
    Maia MS; Osburn BI
    Arch Virol; 1993; 128(3-4):345-56. PubMed ID: 8382039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the roles of bluetongue virus outer capsid proteins VP2 and VP5 in determination of virus serotype.
    Mertens PP; Pedley S; Cowley J; Burroughs JN; Corteyn AH; Jeggo MH; Jennings DM; Gorman BM
    Virology; 1989 Jun; 170(2):561-5. PubMed ID: 2543130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-neutralization of genetic reassortants of bluetongue virus serotypes 20 and 21.
    Cowley JA; Gorman BM
    Vet Microbiol; 1989 Jan; 19(1):37-51. PubMed ID: 2466366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic reassortment of bluetongue virus serotype 11 strains in the bovine.
    Oberst RD; Stott JL; Blanchard-Channell M; Osburn BI
    Vet Microbiol; 1987 Oct; 15(1-2):11-8. PubMed ID: 2830703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of virologic and serologic responses of lambs and calves infected with bluetongue virus serotype 10.
    Richards RG; MacLachlan NJ; Heidner HW; Fuller FJ
    Vet Microbiol; 1988 Dec; 18(3-4):233-42. PubMed ID: 2852871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of cognate dsRNA genome segments of bluetongue virus reassortants by temperature gradient gel electrophoresis.
    Crameri GS; Wang LF; Eaton BT
    J Virol Methods; 1995 Feb; 51(2-3):211-9. PubMed ID: 7738141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of co-circulating serotypes for bluetongue-17 virulence markers.
    Israel BA; Shikuang S; Bernard K; Schultz KT
    Microb Pathog; 1995 May; 18(5):337-44. PubMed ID: 7476098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reassortment of bluetongue virus vaccine serotypes in cattle.
    Van den Bergh C; Coetzee P; Venter EH
    J S Afr Vet Assoc; 2018 Dec; 89(0):e1-e7. PubMed ID: 30551703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virulence-associated antigenic and genetic characteristics of bluetongue virus-17 isolates.
    Bernard KA; Israel BA; Thompson LH; Homan EJ; Schultz KT
    Virology; 1994 Jun; 201(2):321-9. PubMed ID: 8184541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serologic and virologic evidence of bluetongue virus infection in cattle and sheep in Mexico.
    Stott JL; Blanchard-Channell M; Osburn BI; Riemann HP; Obeso RC
    Am J Vet Res; 1989 Mar; 50(3):335-40. PubMed ID: 2539029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens.
    Lobato ZI; Coupar BE; Gray CP; Lunt R; Andrew ME
    Vet Immunol Immunopathol; 1997 Nov; 59(3-4):293-309. PubMed ID: 9477479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological reactions in sheep and cattle experimentally infected with three Australian isolates of bluetongue virus.
    Squire KR
    Aust Vet J; 1989 Aug; 66(8):243-6. PubMed ID: 2556101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A complex neutralization domain of bluetongue virus serotype 17 defines a virulence-associated marker.
    Bernard KA; Israel BA; Schultz KT
    Viral Immunol; 1996; 9(2):97-106. PubMed ID: 8822626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of bluetongue virus neutralization.
    Kahlon J; Sugiyama K; Roy P
    J Virol; 1983 Dec; 48(3):627-32. PubMed ID: 6313962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of bluetongue Disabled Infectious Single Animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimeric VP2.
    Feenstra F; Pap JS; van Rijn PA
    Vaccine; 2015 Feb; 33(6):812-8. PubMed ID: 25510389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High level expression of the two outer capsid proteins of bluetongue virus serotype 10: their relationship with the neutralization of virus infection.
    Marshall JJ; Roy P
    Virus Res; 1990 Mar; 15(3):189-95. PubMed ID: 2160763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the outer capsid proteins of bluetongue virus serotype ten that abrogate neutralization by monoclonal antibodies.
    DeMaula CD; Bonneau KR; MacLachlan NJ
    Virus Res; 2000 Mar; 67(1):59-66. PubMed ID: 10773319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection of cattle in Queensland with bluetongue viruses: 1. Prevalence of antibodies.
    Ward MP; Flanagan M; Baldock FC
    Aust Vet J; 1995 May; 72(5):182-6. PubMed ID: 7661819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group-specific and type-specific gel diffusion precipitin tests for bluetongue virus serotype 20 and related viruses.
    Sharp JM; Littlejohns IR; St George TD
    Aust J Biol Sci; 1988; 41(4):553-62. PubMed ID: 2856013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The coexistence of multiple bluetongue virus electropherotypes in individual cattle during natural infection.
    Oberst RD; Squire KR; Stott JL; Chuang RY; Osburn BI
    J Gen Virol; 1985 Sep; 66 ( Pt 9)():1901-9. PubMed ID: 2993481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.